30 July 2024
Marston's PLC (the "Company") - Notification of Transactions of Directors/Persons Discharging Managerial Responsibility
This notification is made in accordance with the Market Abuse Regulation.
Exercise of option under the Company's Deferred Bonus Plan ("DBP")
On 29 July 2024, the following Director exercised an option over ordinary shares in the Company under the DBP, which was granted on 25 May 2021:
Director | Aggregate number of shares in respect of which DBP exercised
|
Hayleigh Lupino | 30,129 |
Enquiries: Bethan Raybould, General Counsel and Company Secretary, Marston's PLC, +44 (0) 1902 907250
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name | Hayleigh Lupino |
| |||
2
| Reason for the notification | |||||
a)
| Position/status | Director and PDMR (Chief Financial Officer) |
| |||
b)
| Initial notification /Amendment | Initial notification |
| |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a)
| Name | Marston's PLC |
| |||
b)
| LEI | LEI no. 213800Q6RP3ZJ2CZR962 |
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
| Ordinary shares of 7.375p each |
| |||
Identification code | ISIN GB00B1JQDM80 |
| ||||
b)
| Nature of the transaction | Exercise of award under the Deferred Bonus Plan |
| |||
c)
| Price(s) and volume(s) | | | | |
|
| | Price(s) | Volume(s) | |
| |
| | N/A | 30,129 | |
| |
| | | | |
| |
d)
| Aggregated information
- Aggregated volume
- Price
|
n/a single transaction
n/a single transaction |
| |||
e)
| Date of the transaction | 2024-07-29 |
| |||
f)
| Place of the transaction | Outside a trading venue |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.